Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05817825 · ClinicalTrials.gov registry record · NA

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

A NA study of Opioid Use Disorder and Serious Bacterial Infections, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05817825 is a NA study of Opioid Use Disorder and Serious Bacterial Infections that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05817825, a NA study of Opioid Use Disorder and Serious Bacterial Infections, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Interventions

  • BEHAVIORAL Smart IOP Intervention
  • BEHAVIORAL Peer Recovery Coach

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-11-17
Est. Completion 2024-12
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05817825

The ClinicalTrials.gov registry entry for NCT05817825 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Smart IOP Intervention is the first listed.

NCT05817825 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05817825 about?

NCT05817825 is a clinical study titled "Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD". This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

What is the current status of trial NCT05817825?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-11-17. Estimated completion is 2024-12.

What conditions does trial NCT05817825 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Serious Bacterial Infections.

What interventions are being tested in trial NCT05817825?

The interventions under investigation include: Smart IOP Intervention (BEHAVIORAL), Peer Recovery Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT05817825?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05817825 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.